The conviction of one dealer is a tidy media narrative, but it does nothing to disrupt the decentralized networks supplying illicit ketamine. Perry's death highlights a market adapting to new demands, not the actions of a single kingpin. The real question is not who is punished, but who fills the void she leaves behind.
The 15-year sentence for Jasveen Sangha in connection with Matthew Perry's overdose death provides a high-profile conclusion to a tragic event. While the conviction of a single dealer offers a tidy media narrative, it masks the true nature of the illicit ketamine market that supplied the actor. Perry's death is less an indictment of a single "queen" and more a stark indicator of a resilient and adaptive drug supply network responding to demand.
Perry, who had a long-documented struggle with addiction, sourced drugs from a market that is fundamentally decentralized. The removal of one supplier, even a prominent one, does little to disrupt these networks; it merely creates a vacuum. The critical question now is not who has been punished, but which operator will move to fill the supply void left by Sangha's removal, and how their methods might differ to avoid a similar fate.
Get the complete cross-vector breakdown, risk assessment, and actionable intelligence.
Join ESM Insight →